This table presents recent patent oppositions filed by Konig Szynka Tilmann Von Renesse against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4108782Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEMar 7, 2024
EP3265122Combination Of A Pd-1 Antagonist And Eribulin For Treating CancerEISAI R&D MANAGEMENT CO., LTD.Jan 23, 2023
EP3827845Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their UsesJANSSEN BIOTECH, INC.Dec 27, 2022
EP3763820Retroviral Transduction Using PoloxamersHELMHOLTZ ZENTRUM MÜNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)Sep 22, 2022
EP3521422Substantially Animal Protein-Free Recombinat Furin And Methods For Producing SameBAXALTA GMBHJul 6, 2022
EP3498734Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME CORP.Jun 1, 2022
EP3047013Methods And Systems For Processing A Cell CultureGENZYME CORPORATIONMay 18, 2022
EP3440329Fuel Exchange System And Fuel Supply System For Fuel SystemsBEFINAL GMBHNov 17, 2021
EP3218406Binding Molecules Specific For Cd73 And Uses ThereofMEDIMMUNE LIMITEDNov 12, 2021
EP3616720Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYOct 14, 2021